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Group A Streptococcus (GAS), also called Streptococcus pyogenes, is a Gram-positive
beta-hemolytic human pathogen which causes a wide range of mostly self-limiting but also
several life-threatening diseases. Innate immune responses are fundamental for defense
against GAS, yet their activation by pattern recognition receptors (PRRs) and GAS-derived
pathogen-associated molecular patterns (PAMPs) is incompletely understood. In recent
years, the use of animal models together with the powerful tools of human molecular
genetics began shedding light onto the molecular mechanisms of innate immune defense
against GAS. The signaling adaptor MyD88 was found to play a key role in launching the
immune response against GAS in both humans and mice, suggesting that PRRs of the
Toll-like receptor (TLR) family are involved in sensing this pathogen. The specific TLRs and
their ligands have yet to be identified. Following GAS recognition, induction of cytokines
such as TNF and type I interferons (IFNs), leukocyte recruitment, phagocytosis, and the
formation of neutrophil extracellular traps (NETs) have been recognized as key events in
host defense. A comprehensive knowledge of these mechanisms is needed in order to
understand their frequent failure against GAS immune evasion strategies.
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INTRODUCTION
The Gram-positive bacterium group A Streptococcus (GAS), also
named Streptococcus pyogenes, causes a large variety of diseases
ranging from mostly mild pharyngitis and impetigo to serious
post-streptococcal sequelae. In extreme cases, GAS infections lead
to invasive life-threatening diseases such as necrotizing fasciitis
or streptococcal toxic shock syndrome. Severe invasive infections
result in mortality exceeding 25%, and account for more than
650.000 cases each year (Carapetis et al., 2005; Johansson et al.,
2010; Wessels, 2011). The ability of GAS to cause diseases with
multiple clinical manifestations results from virulence factors
which are variably expressed among GAS strains and from dif-
ferent host susceptibilities (Cunningham, 2000; Tart et al., 2007;
Bessen, 2009; Cole et al., 2011; Lynskey et al., 2011).
Upon GAS detection, the immune system launches a com-
plex response which critically depends on the recruitment
and activation of neutrophils, macrophages, and dendritic cells
(DCs) (Goldmann et al., 2004; Loof et al., 2007; Zinkernagel
et al., 2008; Mishalian et al., 2011). These processes are depen-
dent on the activation of innate immune responses by inter-
actions between pattern recognition receptors (PRRs) with
GAS-derived pathogen-associated molecular patterns (PAMPs).
Although advances in human genetics and new animal models
have generated considerable progress in recent years, the individ-
ual components of these interactions and their precise roles in
orchestrating the innate immunity remain incompletely under-
stood (Figure 1). This review focuses on the molecular mecha-
nisms of interactions between innate immune cells and GAS, and
discusses their significance in the outcomes of an infection.
INNATE IMMUNE CELLS IN DEFENSE AGAINST GAS
Despite limitations resulting from differences between the human
and mouse immune systems, numerous studies have highlighted
the value of mouse experiments for establishing the basic prin-
ciples of innate immune defense against GAS. Mouse infection
models were also instrumental for dissecting the roles for indi-
vidual innate immune components in resistance against GAS
infection.
One of the first studies addressing the contribution of
specific innate immune cells to the early control of GAS infec-
tion employed a chemical, namely carrageenan, for deplet-
ing macrophages in mice (Goldmann et al., 2004). The study
demonstrated the requirement for macrophages in limiting GAS
dissemination and increasing mouse survival. Chemical inhi-
bition of phagocytosis with gadolinium III chloride yielded a
phenotype similar to chemical macrophage depletion, hence
emphasizing the importance of phagocytosis for resistance to
GAS. Due to the use of rather unspecific chemical inhibitors,
these initial studies did not address the specific function of
macrophages in the context of complex immune response. This
limitation has been addressed in a recent study by Hanski and
colleagues, who employed genetic means for macrophage deple-
tion (Mishalian et al., 2011). Diphtheria toxin-mediated deple-
tion of CCR2-positive macrophages resulted in an increased
GAS dissemination and higher death rate. Interestingly, TNF-
deficient mice failed to accumulate macrophages at the infection
site whereas the infiltration of neutrophils was not impaired.
These findings implicate that tissue-resident macrophages need
a supportive activity of newly recruited macrophages for the
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FIGURE 1 | Recognition of GAS and activation of innate immune
responses. GAS is recognized by yet not identified TLRs which signal
through MyD88. The signaling cascade triggered by TLRs and MyD88
activates the expression of IFN-β and pro-inflammatory cytokines including
TNF and IL-6. TNF promotes recruitment of macrophages to the infection site
and resistance of mice against GAS. Type I IFN signaling elicited by IFN-β and
other type I IFNs initiate so far poorly understood responses that culminate in
balanced infiltration of neutrophils and protective immune responses against
GAS. TLR13 recognizes bacterial 23S rRNA, including GAS rRNA, and might
be involved in activation of innate immune responses. TLR9 facilitates killing
of GAS by stimulating nitric oxide production. IL-1β is induced by GAS in a
NLRP3-dependent manner but the physiological function of IL-1β remains
unclear. GAS, group A Streptococcus; IFN, interferon; IFNAR, type I IFN
receptor 1; IL-1β, interleukin 1β; NLRP3, NOD-like receptor family, pyrin
domain-containing 3; NO, nitric oxide; ROS, reactive oxygen species; TLR,
Toll-like receptor.
establishment of protective defenses. Although the source remains
to be determined, it is likely that macrophage-derived TNF acts in
autocrine and paracrine ways to facilitate chemotactic relocation
of macrophages to the site of infection. Alternatively, tissue-
resident DCs, alone or in combination with macrophages, may be
the critical source of this cytokine (Loof et al., 2008). Consistent
with a substantial role for DCs, mice genetically depleted of
CD11c+ DCs failed to control GAS dissemination. It remains to
be elucidated whether the major function of DCs in host pro-
tection is the production of TNF or whether other DC-derived
cytokines are also important (Loof et al., 2008). For example, DCs
are a significant source of GAS-elicited IL-12 (Loof et al., 2007,
2008) which stimulates natural killer (NK) cells to generate inter-
feron gamma (IFN-γ). Although a contribution of both IL-12 and
IFN-γ to immune responses against GAS was reported, the spe-
cific function of these cytokines is currently not known (Metzger
et al., 1995; Raeder et al., 2000). As IFN-γ is a major macrophage-
activating cytokine (Nathan et al., 1983), the IFN-γ-generating
DC/NK cell circuit might primarily serve to enhance macrophage
antimicrobial functions. Interestingly, NK cells were reported to
contribute to streptococcal toxic shock syndrome implicating that
unrestricted stimulatory function of NK cells is harmful to the
host (Goldmann et al., 2005a).
Many cytokines and chemokines produced by macrophages
and DCs upon exposure to GAS, most notably IL-1β and CXCL1,
are neutrophil recruitment factors (Harder et al., 2009; Kurupati
et al., 2010). Exhaustion of bone marrow neutrophils and the
resulting impaired infiltration of these cells to the site of infec-
tion increase the susceptibility to GAS (Navarini et al., 2009),
implicating that there is a requirement for neutrophils in host
protection. In agreement, antibody-mediated neutrophil deple-
tion causes an avirulent GAS strain to become hypervirulent
(Hidalgo-Grass et al., 2006). Neutrophils control bacterial infec-
tions largely through the production of antimicrobial peptides,
reactive oxygen species (ROS) and, depending on the pathogen,
neutrophil extracellular traps (NETs). GAS induces an extensive
formation of NETs, which were found to prevent GAS from dis-
semination (Sumby et al., 2005; Buchanan et al., 2006; Lin et al.,
2009). The ability to produce NET-like structures has also been
reported for mast cells (Von Kockritz-Blickwede et al., 2008).
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Consistently, these immune cells are involved in efficient recruit-
ment of leukocytes to the site of infection and clearance of GAS.
Mast cell-deficient mice exhibit a decreased ability to contain
GAS infection in part due to the lack of the mast cell-derived
antimicrobial peptide cathelicidin (Di Nardo et al., 2008).
Although all major innate immune cells non-redundantly par-
ticipate in host protection against GAS, more research is needed
to define the specific roles for individual cell types, and to deci-
pher the cross-talk between them. The role for the adaptive
immune system in GAS infection is, as of yet, less well explored
in mice as most GAS infection models address innate immunity.
SCID mice, i.e., mice deficient in B and T cells, exhibit sim-
ilar resistance against GAS as control mice suggesting a more
profound role for the innate than the adaptive immune sys-
tem (Medina et al., 2001; Goldmann et al., 2005b; Mishalian
et al., 2011). Nonetheless, the importance of adaptive immunity
might be underestimated, as humans lacking the signaling adap-
tor MyD88, which is required for activation of the innate immune
response (see below), are highly susceptible to pyogenic infec-
tions during early life but less in the adulthood (Von Bernuth
et al., 2008). This indicates that adaptive immune responses,
which gradually develop during life, can to some extent substitute
for the innate immune deficiency. The successful use of intra-
venous polyspecific immunoglobulins (IVIG) as adjuvant therapy
corroborates the importance of adaptive immune mechanisms
in protection against GAS (Johansson et al., 2010). In further
support of this, recent studies by Cleary and colleagues uncov-
ered a fundamental contribution of IL-17-producing Th17 cells
to the clearance of GAS in a mouse model of pharyngitis (Wang
et al., 2010; Dileepan et al., 2011). These Th17 cells developed
only upon repeated immunization of mice implicating that these
cells were antigen-specific. Although the precise nature of the
host-protective Th17-dependent mechanism is not known, it can
be assumed that the IL-17-mediated neutrophil expansion will
enhance neutrophil presence in infected tissues. Interestingly, IL-
17 can also be produced by the gammadelta T cells (γδ T cells)
(Martin et al., 2009), which respond in an antigen-independent
way to pathogens and link the adaptive and innate immune sys-
tems. Future studies should investigate whether IL-17 helps in
the eradication of GAS in adult human patients deficient in the
MyD88-dependent first line of defense (Von Bernuth et al., 2008).
PRRs IN GAS INFECTION
Innate immune responses are triggered by interactions of PRRs
with the cognate PAMPs (Medzhitov and Janeway, 2000; Takeuchi
and Akira, 2010). PRR ligation by PAMP activates signaling cas-
cades which lead to the production of cytokines and chemokines,
and ultimately, to the recruitment of additional immune cells
to the site of infection. TLRs are a membrane-bound subset
of PRRs, which stimulate immune cells by activating the tran-
scription factor NFκB, but also the IRF family of transcription
factors (Medzhitov et al., 1997; Kawai and Akira, 2010). TLRs
signal mainly via the signaling adaptor MyD88 but also through
TIR-domain-containing adapter-inducing interferon-β (TRIF)
and TIR domain-containing adaptor protein (TIRAP)/MyD88
adaptor-like (Mal) (Medzhitov et al., 1998; Horng et al., 2001;
Yamamoto et al., 2002; Oshiumi et al., 2003). TLRs are expressed
on most innate immune cells as well as some adaptive immune
cells. Epithelial and endothelial cells can also upregulate TLR
expression upon stimulation (Kagnoff and Eckmann, 1997;
Andonegui et al., 2003; Iwasaki and Medzhitov, 2004). Cytosolic
PRRs include the RIG-I-, NOD-, and AIM2-like receptors (RLRs,
NLRs, and ALRs, respectively) which recognize a variety of
PAMPs and danger-associated molecular patterns (DAMPs), with
various nucleic acids being the best characterized class of them
(Franchi et al., 2008; Alnemri, 2010; Bauernfeind and Hornung,
2013; Ferrand and Ferrero, 2013). The family of nucleic acid-
sensing cytosolic PRRs also includes the newly characterized DNA
sensor cGAS (Ablasser et al., 2013; Li et al., 2013).
MyD88 is needed for launching a functional inflammatory
response to GAS infection (Loof et al., 2008, 2010). MyD88 defi-
ciency results in a dramatically decreased production by phago-
cytic cells of TNF, IL-6, IL-12, type I interferons (IFNs), and
possibly most other cytokines and chemokines (Gratz et al., 2008,
2011; Loof et al., 2008, 2010) (Figure 1). Consequently, mice lack-
ingMyD88 exhibit impaired recruitment of neutrophils to the site
of infection and a higher susceptibility to GAS challenge (Loof
et al., 2008, 2010). Consistently, TNF, one of the major pro-
inflammatory cytokines generated downstream of TLR/MyD88
signaling, is required for the rapid recruitment of macrophages
to the infected tissue and for prevention of invasion by GAS
(Mishalian et al., 2011). Similarly, type I IFNs, which are induced
in a largely MyD88-dependent manner, are critical for host
defense as mice deficient in the type I IFN receptor 1 (IFNAR-1)
exhibit higher susceptibility in a model of invasive GAS infection
(Gratz et al., 2011) (Figure 1). An increased accumulation of neu-
trophils in the infected tissue of IFNAR-1-deficient mice suggests
that other mechanisms than insufficient immune responses are
responsible for the exacerbated GAS infection in the absence of
type I IFN signaling. Despite the clear requirement for MyD88
in GAS-elicited production of key cytokines, the TLRs engaged
by GAS upstream of MyD88 are not known. A number of stud-
ies demonstrated that primary innate immune cells derived from
mice deficient in TLR1, TLR2, TLR4, TLR9, or TLR2/6 double-
deficient, or TLR2/4/9 triple-deficient, were still able to produce
inflammatory cytokines in response to GAS (Gratz et al., 2008;
Loof et al., 2008, 2010). In particular, the absence of a substan-
tial effect of TLR2 deficiency is surprising as this TLR is generally
involved in the recognition of Gram-positive bacteria. It should
be noted that these experiments mostly employed infection of
cells rather than mice, so that the TLRs tested might still play
a role in the context of a whole animal infection. In support of
this, TLR9, although not required for cytokine induction in vitro,
facilitates intracellular killing of GAS by inducing the production
of reactive oxygen species and nitric oxide (NO) in macrophages
(Zinkernagel et al., 2012). In contrast, mice lacking TLR2 appear
to be only modestly more susceptible to GAS infection as the
difference with control mice is not significant (Mishalian et al.,
2011). Interestingly, similarly moderate increase in susceptibility
was also observed in mice deficient in the monocyte-attracting
CCL2 chemokine receptor CCR2 despite the importance of
monocytes recruitment for resistance against GAS (Mishalian
et al., 2011). Since the lack of CCR2 reduces the number of circu-
lating monocytes by 80%, these observations clearly suggest that
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mice possess highly potent and possibly redundant macrophage
activation pathways, which allow the establishment of a protective
response against GAS also under conditions of greatly reduced
macrophage numbers. Similar explanations might apply to the
lack of a substantially higher susceptibility of TLR2-deleted mice.
GAS can trigger PRRs other than TLRs, as demonstrated by
the induction of IL-1β in mouse macrophages (Harder et al.,
2009). IL-1β production requires the NLRP3 inflammasome and
depends on the expression of the GAS-derived cytolysin strep-
tolysin O (SLO). Despite the strong induction of IL-1β by GAS,
there is no evidence that this cytokine is required for a successful
defense since NLRP3-deficient mice exhibit a similar susceptibil-
ity to intraperitoneal GAS infection as control animals (Harder
et al., 2009). Thus, the GAS-specific function of IL-1β, one of the
most potent inflammatory cytokines, remains to be identified.
GAS-derived PAMPs triggering MyD88-dependent or -
independent responses are as enigmatic as the corresponding
PRRs. Peptidoglycan purified from GAS can activate TLR2
(Schwandner et al., 1999), however, as mentioned above, no
major contribution of TLR2 to responses elicited by live GAS
can be observed. Possible explanations for these findings include
a redundancy of TLR receptors or the masking of peptidogly-
can in intact GAS by e.g., the hyaluronic acid capsule which is
a critical immune evasion factor (Stollerman and Dale, 2008). In
the latter scenario, peptidoglycan would become accessible only
upon phagocytosis and the subsequent degradation of internal-
ized GAS. The phagosome-specific configuration of TLRs may
prevent substantial TLR2 responses yet allow other TLRs to be
triggered by PAMPs distinct from TLR2 ligands. Such PAMPs
include GAS-derived nucleic acids which act as PAMPs induc-
ing IFN-β (a type I IFN) (Gratz et al., 2011). Interestingly, GAS
RNA triggers IFN-β production in a MyD88-dependent manner
in DCs, but it fails inducing this cytokine in macrophages, sug-
gesting that more attention needs to be paid to cell type-specific
PRR-PAMP interactions.
Together, despite the fundamental importance of the signal-
ing adaptor MyD88 for protection against GAS infection, the
upstream TLRs as well as the precise nature of their ligands
remain to be elucidated. Similarly, the mechanism of the NLRP3
inflammasome activation requires further investigations. Future
studies should also address the in vivo role for the recently char-
acterized TLR13, aMyD88-dependent receptor, which specifically
recognizes bacterial 23S rRNA, including GAS rRNA (Hidmark
et al., 2012; Li and Chen, 2012; Oldenburg et al., 2012). As TLR13
is expressed in mice but not humans, it is intriguing whether
any of the human TLRs can substitute for the TLR13-mediated
responses.
EVASION OF INNATE IMMUNE RESPONSES
GAS possesses a large variety of strategies to evade the host
immune response (Figure 2). To avoid the first line of defense, i.e.,
phagocytic cells, GAS employs antiphagocytic virulence factors
such as the M1 protein and the hyaluronic acid capsule (Moses
et al., 1997). Phagocytosis is an efficient host defense mecha-
nism as the vast majority of internalized GAS is rapidly killed.
Phagocytosed GAS can increase its survival by the expression of
the pore-forming cytolysin SLO which inhibits the transport of
GAS to lysosomes and facilitates escape of GAS from lysosomes
(Nakagawa et al., 2004; Hakansson et al., 2005). SLO has a more
general function in immune evasion since it also induces cell
death in macrophages and neutrophils (Goldmann et al., 2009;
Timmer et al., 2009). GAS expresses yet another pore-forming
toxin, the cytolysin SLS, which inhibits neutrophil recruitment
to the site of infection by blocking the production of chemo-
tactic signals (Lin et al., 2009). Neutrophils are also targeted by
the prophage-encoded nucleases Sda1 and SpnA. These secreted
DNases attenuate the host antimicrobial mechanisms by degrad-
ing NETs and liberating the entrapped GAS (Sumby et al., 2005;
Buchanan et al., 2006; Walker et al., 2007; Chang et al., 2011).
In addition to degrading NETs, GAS can dissolve blood clots
via the secreted GAS protease streptokinase (Ska). Ska activates
plasminogen by converting it into plasmin which is deposited
on the cell surface of GAS and helps degrading fibrin clots and
promotes GAS dissemination (Sun et al., 2004). GAS secreted
proteases also play a key role in blunting chemokine activities.
The proteinase SpeCYP interferes with neutrophil recruitment
by cleaving and inactivating the neutrophil chemoattractants IL-
8 in humans, as well as CXCL1 and CXCL2 in mice (Edwards
et al., 2005; Hidalgo-Grass et al., 2006). Another immune eva-
sion strategy is the blockage of the complement system. GAS
impedes complement deposition by cleaving C5a, an impor-
tant inducer of neutrophil recruitment, by the C5a peptidase
as well as the anchorless surface dehydrogenase (Cleary et al.,
1992; Terao et al., 2006). Streptococcal inhibitor of complement
(SIC) inhibits complement-mediated formation of themembrane
attack complex (MAC) and decreases antimicrobial peptide pro-
duction by neutrophils (Akesson et al., 1996; Hoe et al., 2002;
Frick et al., 2003). The M1 protein can bind the host Factor H,
a potent inhibitor of complement deposition and phagocytosis.
Surprisingly, a recent study has demonstrated that binding of
Factor H to M1 does not interfere with phagocytosis (Gustafsson
et al., 2013) implicating that the function of some virulence
factors may not be correctly annotated. A broader use of human-
ized mice will further improve the functional characterization of
GAS evasion mechanisms, as exemplified by mice expressing the
human plasminogen (Sun et al., 2004).
CONCLUSIONS
The wealth of in vitro data, infection studies and human genet-
ics demonstrate a crucial role of the innate immune system in
protection against GAS infection. Yet, our knowledge of specific
interactions between PRRs and PAMPs is surprisingly limited.
This knowledge is needed to design new strategies for treat-
ments of severe GAS infections. Such strategies should include
the development of PRR agonists and antagonists, which might
help adjusting the immune responses so that they precisely match
the extent and tissue-specific features of the bacterial challenge.
A better understanding of PRR-PAMP interactions could also
reveal additional mechanisms underlying the highly variable sus-
ceptibility to GAS infections among humans. Future studies
should employ more sophisticated animal models, including con-
ditional and/or inducible gene ablations and multiple knockouts
to address tissue specificity and redundancy in responses to GAS.
The use of CRISPR-Cas9-mediated genome editing, which was
Frontiers in Cellular and Infection Microbiology www.frontiersin.org October 2014 | Volume 4 | Article 140 | 4
Fieber and Kovarik Immunity to group A Streptococcus
FIGURE 2 | Evasion of innate immunity by GAS. (I)M protein, F proteins of
pili and the hyaluronic acid capsule are involved in adhesion and/or invasion;
(II) SLO, hyaluronic acid capsule and M-proteins inhibit phagocytosis and help
avoid killing of GAS within phagolysosomes; (III) Secreted GAS factors inhibit
complement activation and antimicrobial peptides (C5a peptidase, SIC),
prevent phagocyte recruitment (C5a peptidase), induce apoptosis of
phagocytes (SLO), interfere with cytokines or cytokine production (SLS,
SpeCYP), destroy NETs (DNases). AMP, antimicrobial peptide; NET, neutrophil
extracellular trap; SIC, streptococcal inhibitor of complement; SLO,
streptolysin O; SLS, streptolysin S.
first described using GAS as a CRISPR model (Jinek et al., 2012),
should facilitate the development of new cell culture models,
particularly in the human system. As GAS is a human-specific
pathogen, the combination of mouse models with cell-based
experiments in the human system together with molecular epi-
demiology studies are critical for filling up the blank spots on the
map of immune responses to GAS.
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